drugset / Trial / NCT01473316

Study to Determine the Effect of Ketoconazole on the Pharmacokinetics of GDC-0980

NCT01473316

Phase 1 Completed 22 enrolled Genentech, Inc.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This will be an open-label, fixed-sequence, single-center, 2 period study. The study is designed to determine the effect of ketoconazole on the pharmacokinetics of GDC-0980.

Timeline

Start
2011-11
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Apitolisib Small molecule Oral
Subject Ketoconazole Small molecule Oral

Indications

No indication recorded.